Lung transplantation in the era of new drugs

Symposium
Chairs: J. van Meerbeeck (Edegem (Antwerp), Belgium), F. Meloni (Pavia (PV), Italy)
Aims: To describe the effects of new therapeutic strategies in patients with pulmonary hypertension (PH), interstitial lung diseases (ILD) and cystic fibrosis (CF) on needs and indications for lung transplantation; and to evaluate outcomes of lung transplantation for these three indications.
The need for lung transplantation in cystic fibrosis (CF) in the era of new treatment
C. Benden (Zurich, Switzerland)
WebcastSlide presentation
WebcastSlide presentation
New antifibrotic drugs: will interstitial diseases patients still need lung transplantation?
S. Tomassetti (Florence, Italy)
WebcastSlide presentation
WebcastSlide presentation
New issues in lung transplantation for pulmonary hypertension
M. Delcroix (Leuven, Belgium)
WebcastSlide presentation
WebcastSlide presentation
Figures and outcomes of lung transplantation
J. Gottlieb (Hannover, Germany)
WebcastSlide presentation
WebcastSlide presentation